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Lipid metabolism regulation is effected by the neuroendocrine system 
(3, 11, 16, 17,24). An inportant role in this respect is attributed to the system 
hypothalamus — hypophysis — adrenal cortex. The hypothalamus exerts its 
influence on lipid metabolism intensity through the endocrine glands. 
In 1964, Lee (cit. 5, 10) succeeded in isolating from the hypophysis of an-
imals and humans a fraction with peptide structure, coined with the term l i -
potropic This free of S T H and ACTH-content polypeptide has a prono-
unced lipolytic effect. (21, 22). Lipotropin has been demonstrated in the blo-
od of humans after receiving large fat amounts with the food. This substance 
is never detected in the blood of patients with hypopituitarism and in post-
hypophysectomy conditions (21). In 1956, Leytes and co-workers (cit. 1, 10) 
isolated an analogical substance from the hypophysis of animals, denomin-
ated adiposin. The latter lipolytic substance is also known as lipomobilizing 
factor (11,12) or hormone (27). Hartman (1947) isolated a «fatty» factor from 
the adrenal cortex promoting the mobilization of lipids from the fat deposits 
towards the liver (cit. 6). The regulatory effect on fat metabolism exerted by 
a number of hormones, such as A C T H , S T H , T T H , G T H etc has been accordin-
gly proved. The adrenals likewise participate actively in the regulation of 
lipid metabolism. 
A C T H has a pronounced lipolytic effect — it lowers the level of serum 
cholesterol (4, 10, 11, 16, 20, 25, 26, 28). Furthermore, it stimulates the mo-
bilization of fats from the deposits, and their utilization in the tissues (19,18). 
On the contrary, Adlersberg et al (cit. 20) do not rule out the possibility of 
cholesterol level increase, intense fatty deposition in the tissue, and their re-
distribution. Literature data concerning the lipomobilizing effect of glyco-
corticoids are controversial: e. g. it is claimed equally that they may enhance 
(18), as well as inhibit lipolysis (7). Under the influence of glycocorticoids, 
the blood cholesterol level rises (4, 15, 23). Leytes (8) and Stork (29) establis-
hed that cortisone exerts no influence on lipolysis, in vitro, whereas, in vivo, 
it accounts for its insignificant inhibition. Most probably, glycocorticoids 
do not have an independent, immediate lipomobilizing effect, but rather a 
permissive effect, on the factors promoting mobilization and utilization of 
fats (9, 11, 19). Leytes and Davtyan (9) observed a permissive effect of corti-
sone in terms of the lipomolibizing action of epinephrine. 
Hyperpituitarism is characterized by an increased blood level of cho-
lesterol, phospholipids and beta-lipoproteins, whereas in hypopituitarism the 
listed above indicators are reduced or within normal limits (17). Ganelina (24) 
established a considerable rise of the cholesterol and total lipids content in 
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the blood, and reduced lipoprotein lipase activity in patients with dience-
phalic syndrome. In Itzenko-Cushirig's disease, similarly an overall increase 
of the serum lipid level and endogenic heparin level, not correlating with the 
lowered activity of lipoprotein lipase, is established (13, 14). The mechanisms 
of the described above lipid metabolism disorders are not sufficiently well 
clarified, with a great importance being attributed to the lowered lipopro-
tein lipase activity (14). 
It is the purpose of the present work to study the activity of lipoprotein 
lipase, and the changes in serum lipids' content in diencephalic syndrome 
of the Itzenko-Cushing type, and in I tzenko—Cushing's disease. 
Material and methods 
The heparin test was dispensed in a series of 14 patients with dience 
phalic syndrome of the Itzenko-Cushing type, in 10 patients with Itzenko" 
Cushing's disease, and in 17 clinically healthy individuals. 
We accepted that it was a matter of diencephalic syndrome of the type 
of Itzenko-Cushing's disease in cases of primary lesion in the hypothalamus area 
with disturbed function of the system hypothalamus-hypophysis-adrenal cor-
tex, and appearance of early, not invariably clearly manifested symptoms, 
characterise of the disease of Itzenko-Cushing. The consistent involvement 
of the adrenal cortex in the pathological process of the above described disor-
ders was interpreted as presence of Itzenko-Cushing's disease (3). 
The heparin test and the methods employed in the study of serum lipids 
were outlined in an earlier work (2). 
Results 
Among the patients with diencephalic syndrome of the Itzenko-CushinS 
type, compared to patients with Itzenko-Cushing's disease (Table 1), a statis-
tically significantly lower level of cholesterol, total lipids, phospholipids, 
beta-lipoproteins, endogenic heparin and blood sugar was established, at con-
siderably enhanced lipoprotein lipase activity. As far as triglyceride and non-
esterified fatty acids content is concerned, no essential difference is found be-
tween the two morbid conditions. 
In the group of patients wfth diencephalic syndrome of the Itzenko-Cu-
shing type, as compared to healthy individuals, a statistically significantly 
lower cholesterol and endogenic heparin level is established, and a higher le-
vel of beta-lipoproteins. The other findings show a lower lipoprotein lipase ac-
tivity, and higher level of total lipids and triglycerides, but the latter diffe-
rence proved statistically insignificant (Table 1). 
Upon comparison of the serum lipids blood content and lipoprotein l i -
pase in the groups under study and in patients with acromegaly (2), it was fo-
und out that among the patients with Itzenko-Cushing's disease, the level of 
cholesterol, total lipids and beta-lipoproteins was the highest, and the acti-
vity of lipoprotein lipase — the lowest. 
Under the influence of the heparin administered in patients with dience-
phalic syndrome of the Itzenko-Cushing type (Table 2), a statistically signi-
ficant reduction of the blood content of cholesterol, total lipids, phospholi-
pids, triglycerides and beta-lipoproteins occurs, along with an increase of 
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non-esterified fatty and endogenic heparin. In cases with Itzenko-Cushing's 
disease heparin exert an analogical effect (Table 3). 
7 a b l e 1 
Correlation between the Content of Serum Lipids, Endogenic Heparin, 
Lipoprotein Lipase and Blood Sugar in Patients with Diencephalic Syndrome 
of the ItzenKo-Cushing Type, Itzenko-Cushing's Disease 






n = 10 
M i r 
Cholesterol mg % 
Total lipids mg % 
Phospholipids mg % 
Triglycerides mg % 
;i-lipoproteins FU 
Non-esterified f. a. |i M/ml 
Lipoprotein lipase \i M/ml 
Endogenic heparin U/ml 

















































T a b l е 
Heparin Effect on the Blood Content of Lipids in Patients with 
Diencephalic Syndrome of the ItzenKo-Cushing Type 
Cholesterol rng % 
Total lipids mg % 
Phospholipids mg % 
Triglycerides mg % 
^-lipoproteins F U 
Non-esterified f. a. u- M/ml 
Lipoprotein lipase ;i M/ml 























T a b l e 3 




Post-hep arln value 
M ±t P 
Cholesterol mg % 
Total lipids mg % 
Phospholipids mg % 
Triglycerides mg % 
^-lipoproteins F U 
Non-esterified f. a. i± M/ml 
Lipoprotein lipase jx M/ml 
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Discussion 
The results of our study point to presence of a serious lipid metabolism 
derangement in the groups under observation. 
In cases with diencephalic sundrome, Ganelina (24) noted an increase of 
cholesterol and total lipids mainly, and a reduction of lipoprotein lipase ac­
tivity. In our series of diencephalic syndrome patients, in comparison with 
healthy subjects, the cholesterol level appears to be lower and the endogenic 
heparin content as well which correlates with the reduced lipoprotein lipase 
activity. The lowered cholesterol level and the moderately raised levels of the 
other lipid indicators in our series are most probably attributable to the enha­
nced A C T H production, to its lipolytic and cholesterol-level reducing effect. 
This is in harmony with the observations made by various authors (4, 11, 16, 
28). I t is by no means ruled out that at this particular stage of the disease, 
parallel to the increase of A C T H , the activity of the lipomobilizing hormone 
of the hypophysis (adiposin) is also enhanced, and exerts an additional influ­
ence on serum lipids. 
Similar to other authors (14), we too established a particularly low lipo­
protein lipase activity which does not correlate with the normal endogenic he­
parin level. The lipoprotein lipase fall is most likely due to the increased ac­
tivity of its inhibitors. We are propense to accept that the considerable vari­
ations in lipid fractions, observed among the Itzenko-Cushing's disease pati­
ents, are caused by the lowered activity of lipoprotein lipase in these pati­
ents. 
The statistically significantly lower blood sugar level (p<0.02) in the 
healthy subjects, relative to patients with Itzenko-Cushing's disease, point 
to the existence of a close interrelation betveen carbohydrate and lipid meta­
bolism in this affection. 
Under the effect of heparin, a considerable lipolysis takes place, involv­
ing al l the lipid fractions, in both groups of patients under study. Usually, 
such a lipolytic effect is exerted by heparin in association with a severe lipid 
metabolism disturbance. 
; The substantial increase in practically al l lipid fractions of the blood in 
Itzenko-Cushing's disease may be used as an additional test in the diagno­
sis of the condition. 
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ЛИПИДНЫЙ ОБМЕН ПРИ ДИЗНЦЕФАЛЬНОМ СИНДРОМЕ 
ТИПА БОЛЕЗНИ И Ц Е Н К О - К У Ш И Н Г А 
И ПРИ БОЛЕЗНИ ИЦЕНКО-КУШИНГА 
Г. Вырбонов 
Р Е З Ю М Е 
Линопротеиновая липаза, эндогенный гепарин и сывороточные липи-
ды исследованы у 14 больных с диэицефальным синдромом типа Иценко-
Кушинга, у 10 больных с болезнью Иценко—Кушинга и у 17 клинически 
здоровых лиц. 
У больных с болезнью Иценко—Кушинга по сравнению с больными 
с диэицефальным синдромом установлены статистически значимые более вы­
сокие величины холестерина, общих липидов, фосфолипидов, [j-липопро-
теипов и эндогенного гепарина. Налицо серьезное нарушение линидного 
обмена, касающееся всех липидных фракций. 
